News from endo international plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

06 Jun, 2019, 12:30 BST Nationally Recognized Urologist and Author, Aaron Spitz, MD, Teams Up with Endo Pharmaceuticals' Ask About the Curve Campaign to Encourage Men to Get "In Touch" With Their Anatomy This Men's Health Month

Ask About the Curve raises awareness of Peyronie's disease, a men's health condition that may affect about 1 in 10 men and leads to a pronounced...


17 May, 2019, 12:00 BST Phase 3 Data of Collagenase Clostridium Histolyticum for the Investigational Treatment of Cellulite to Be Presented at The Aesthetic Meeting 2019

Endo International plc (NASDAQ: ENDP) today announced that clinical data from a Phase 3 investigational study of collagenase clostridium histolyticum ...


15 May, 2019, 22:00 BST Endo to Participate at RBC Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the RBC Annual Healthcare...


09 May, 2019, 11:30 BST Endo Reports First-Quarter 2019 Financial Results

First-quarter 2019 revenues increased 3 percent to $720 million compared to first-quarter 2018 revenues of $701 million First-quarter 2019 Sterile...


01 May, 2019, 22:49 BST Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall of One Lot of Mycophenolate Mofetil for Injection, USP Due to the Presence of a Glass Fragment Observed in One Vial of Reconstituted Product

Endo International plc, announced today that one of its operating companies, Par Pharmaceutical, Inc., is voluntarily recalling one lot of...


10 Apr, 2019, 22:00 BST Endo to Announce First-Quarter 2019 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2019 financial results on May 9, 2019 and members of its senior management team ...


05 Apr, 2019, 12:30 BST Endo Begins Shipment of Authorized Generic Version of PROVENTIL® (albuterol sulfate) HFA Inhalation Aerosol in the United States

Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized ...


28 Mar, 2019, 01:25 GMT Endo International plc Announces Early Tender Results of its Previously Announced Cash Tender Offers and Consent Solicitations for up to $1.5 billion Aggregate Purchase Price of its Outstanding Senior Notes

Endo International plc (NASDAQ: ENDP) (the "Company" or "Endo") today announced the early tender results of the previously announced cash tender...


19 Mar, 2019, 11:30 GMT Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery

Endo International plc (NASDAQ: ENDP) today announced the publication of Phase 2 data evaluating collagenase clostridium histolyticum (or "CCH") for...


15 Mar, 2019, 00:17 GMT Endo International plc Announces Pricing of Private Offering Of Senior Secured Notes

Endo International plc (NASDAQ: ENDP) ("Endo") today announced that Par Pharmaceutical, Inc. (the "Issuer"), its wholly-owned subsidiary, priced $1.5 ...


15 Mar, 2019, 00:16 GMT Endo International plc Announces an Upsizing of its Cash Tender Offers and Consent Solicitations

Endo International plc (NASDAQ: ENDP) today announced an upsizing of its previously announced cash tender offers (the "Tender Offers") and consent...


14 Mar, 2019, 12:07 GMT Endo International plc Announces Debt Refinancing Transactions, Including Cash Tender Offers and Consent Solicitations for up to $1.0 billion Aggregate Purchase Price of its Outstanding Senior Notes

Endo International plc (NASDAQ: ENDP) today announced a series of debt refinancing transactions that are intended to help manage the debt maturity...


14 Mar, 2019, 12:02 GMT Endo International plc Announces Proposed Private Offering Of Senior Secured Notes

Endo International plc (NASDAQ: ENDP) ("Endo") today announced that Par Pharmaceutical, Inc. (the "Issuer"), its wholly-owned subsidiary, intends to...


04 Mar, 2019, 13:00 GMT Endo to Participate at Cowen & Company 39th Annual Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Cowen & Company 39th...


01 Mar, 2019, 20:40 GMT Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List

Endo International plc ("Endo") (NASDAQ: ENDP) today announced that the U.S. Food and Drug Administration (FDA) has determined that there is no...


01 Mar, 2019, 12:30 GMT Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting

Endo International plc (NASDAQ: ENDP) today announced that it will present new data showing collagenase clostridium histolyticum (CCH) significantly...


28 Feb, 2019, 11:30 GMT Endo Reports Fourth-Quarter And Full Year 2018 Financial Results

Fourth-quarter 2018 revenues increased 2 percent to $786 million Fourth-quarter 2018 Sterile Injectables revenues increased 32 percent to $259...


27 Feb, 2019, 22:21 GMT Endo Announces Termination of Acquisition Agreements with Somerset Therapeutics and Business of Affiliate Wintac Limited

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Endo Ventures Limited, Par Pharmaceutical, Inc. and Par Formulations...


07 Feb, 2019, 13:00 GMT Endo Agrees Not To Oppose Additional Stay of FDA Litigation Following Restoration of Government Appropriations

Endo International plc ("Endo") (NASDAQ: ENDP) today announced that the U.S. Food and Drug Administration (the "FDA") has requested a further stay of ...


25 Jan, 2019, 22:53 GMT Endo to Announce Fourth-Quarter and Full-Year 2018 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2018 financial results on February 28, 2019 and members of its...


31 Dec, 2018, 12:30 GMT Endo Announces Anticipated Further Stay of Compounding Litigation Due to Lapse of Government Appropriations

Endo International plc ("Endo"; NASDAQ: ENDP) today announced that, due to the ongoing federal government shutdown, the U.S. Food and Drug...


19 Dec, 2018, 12:30 GMT Endo to Participate at J.P. Morgan Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference in San...


28 Nov, 2018, 21:46 GMT Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill...


26 Nov, 2018, 18:03 GMT Endo to Participate at Piper Jaffray Global Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Piper Jaffray Global...


08 Nov, 2018, 12:00 GMT Endo Reports Third-Quarter 2018 Financial Results

Third-quarter 2018 revenues of $745 million compared to third-quarter 2017 revenues of $787 million Third-quarter 2018 XIAFLEX® franchise revenues...